Always Remember - Buy The Dip

Sentiment Analysis For MNKD

The news is currently generally neutral for MNKD.

Based on TextBlob analysis of Yahoo! Finance news summaries for MNKD on 2015-08-22.

Yahoo! Finance News for MNKD

3 Biotech Stocks That Are Getting a Heckuva Lot Riskier
Source Flickr user State Farm A never ending stream of new drugs making their way to market makes biotech stocks especially prone to jaw dropping pops and drops, and the industry's

3 Biotech Stocks Wall Street Hates
Short sellers have been piling into healthcare stocks this year, especially among companies with comparatively small market caps. While the global economic headwinds such as the Greek and Puerto Rican financial meltdowns have potentially been

Notable option activity in equities
Nearing the halfway mark in today's session, here are the individual equity names with unusual option activity on optionMONSTER's ActionTracker data system. MannKind (MNKD) About 5,000 September 4.50 calls were sold for $0.27 as investors bet upside will be

MannKind (MNKD) Reports Narrower-than-Expected Q2 Loss
MannKind Corp . MNKD reported a loss of 7 cents per share in the second quarter of 2015, narrower than the Zacks Consensus Estimate of a loss of 8 cents and the year ago loss of 19 cents. Mannkind

MannKind Q2 15 Earnings Conference Call At 9:00 AM ET
MannKind Q2 15 Earnings Conference Call At 9:00 AM ET

Why MannKind Got the Unkind Treatment From Investors in July
Shares of MannKind , a biopharmaceutical company focused on developing medicines to treat diabetes, plunged 25% in July based on data from S&P Capital IQ following the release of disappointing sales results for

Notable option activity in equities
Nearing the halfway mark in today's session, here are the individual equity names with unusual option activity on optionMONSTER's ActionTracker data system. MannKind (MNKD) About 20,000 January 5 calls were bought for $0.61 to $0.66 as investors looked for

3 Stocks that Are Fool's Gold
Investing in stocks is one of the best ways to build wealth over time, as the returns that are available from the market's best high growth companies are simply extraordinary. If you can find and

Why MannKind Corp. Stock Briefly Dropped Today
What MannKind Corp .'s stock briefly fell by 11% today after its marketing partner Sanofi reported its second quarter sales for the inhaled insulin product Afrezza. According to the press release,

Why MannKind Corp.'s Stock Slumped Today
What Shares of MannKind Corp. fell by nearly 10% this morning on heavy volume after the company revealed its plan for repaying $100 million worth of Senior notes due in about

MNKD September 4th Options Begin Trading
Investors in MannKind Corp (Symbol MNKD) saw new options begin trading today, for the September 4th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the MNKD options chain for the new September 4th

The Reason MannKind Stock Galloped 10% Higher in June
Shares of MannKind , a biopharmaceutical company focused on the development of therapies to treat diabetes, surged by 10% in June (per S&P Capital IQ ) following positive analyst commentary and a likely

Interesting MNKD Put And Call Options For August 14th
Investors in MannKind Corp (Symbol MNKD) saw new options begin trading today, for the August 14th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the MNKD options chain for the new August 14th

MNKD Crosses Below Key Moving Average Level
In trading on Monday, shares of MannKind Corp (Symbol MNKD) crossed below their 200 day moving average of $5.64, changing hands as low as $5.63 per share. MannKind Corp shares are currently trading off about 3.3% on the day.

3 Biotech Stocks with Low Liquidity Ratios -- Are They in Trouble?
Source Wikimedia Commons Biotech stocks don't come with labels that warn investors of potential dangers ahead. There is something that comes close, though. The current ratio is a key metric

MannKind To Present At JMP Securities Conference; Webcast At 9:30 AM ET
MannKind To Present At JMP Securities Conference; Webcast At 9:30 AM ET

First Week of February 2016 Options Trading For MannKind (MNKD)
Investors in MannKind Corp (Symbol MNKD) saw new options begin trading this week, for the February 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value,

MannKind Corp. To Present At Goldman Sachs Conference; Webcast At 11:40 AM ET
MannKind Corp. To Present At Goldman Sachs Conference; Webcast At 11:40 AM ET

MannKind Corp. To Present At Jefferies Global Conference; Webcast At 2:00 PM ET
MannKind Corp. To Present At Jefferies Global Conference; Webcast At 2:00 PM ET